Expanded Access for Retatrutide in Severe Obesity Announced | Retatrutide News

Eli Lilly is offering pre-approval expanded access to retatrutide for severely obese adults. This move targets individuals with a BMI ≥35 kg/m² and seri...
Clinical Trials · October 11, 2026